Keith Murphy

Keith Murphy was the founder of VivoSim Labs, Inc., founded in 2007, where the title held was Chairman in 2017.
Mr. Murphy was the founder of Organovo, Inc., founded in 2012, where the title held was Chairman, President & Chief Executive Officer in 2017.
Mr. Murphy is the founder of Viscient Biosciences LLC, founded in 2017, holding the titles of Chairman & Chief Executive Officer since 2017.
Current jobs included Executive Chairman, CEO & Secretary at VivoSim Labs, Inc. since 2020; Co-Chairman at No Patient Left Behind; Director at California Biomedical Innovation Alliance since 2016; Director at California Life Sciences Association; Independent Director at Matinas BioPharma Holdings, Inc. starting 2025; and Executive Advisor at Methuselah Capital Management LLC.
Former jobs include Vice Chairman at Alliance for Regenerative Medicine; Director-Process Development at Amgen, Inc. from 1997 to 2007; Independent Director at Kintara Therapeutics, Inc. from 2020 to 2022; Director at Adgero Biopharmaceuticals Holdings, Inc.; and Head-Development at Alkermes Plc from 1993 to 1997.
Education includes an undergraduate degree from Massachusetts Institute of Technology conferred in 2004 and a graduate degree from UCLA Anderson School of Management conferred in 1993.